ADAR1 Capital Management, LLC insider trades: NextCure (NXTC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where ADAR1 Capital Management, LLC reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | NXTC | ↑ Buy | 10,851 | $4.95 | $54K | Indirect | Oct 27, 2026 (0d) |
| Oct 23, 2026 | INM | ↑ Buy | 4 | $1.32 | $5 | Indirect | Oct 27, 2026 (4d) |
| Oct 21, 2026 | TENX | ↑ Buy | 922,849 | $1.59 | $1.5M | Indirect | Oct 21, 2026 (0d) |
| Oct 19, 2026 | INM | ↑ Buy | 1,087 | $1.32 | $1K | Indirect | Oct 20, 2026 (1d) |
| Oct 15, 2026 | INM | ↑ Buy | 9,569 | $1.33 | $13K | Indirect | Oct 15, 2026 (0d) |
| Oct 8, 2026 | INM | ↑ Buy | 10,903 | $1.33 | $14K | Indirect | Oct 8, 2026 (0d) |
| Oct 5, 2026 | INM | ↑ Buy | 42,920 | $1.33 | $57K | Indirect | Oct 5, 2026 (0d) |
| Sep 16, 2026 | INM | ↑ Buy | 91,101 | $1.30 | $118K | Indirect | Sep 16, 2026 (0d) |
| Sep 3, 2026 | TENX | ↑ Buy | 900,000 | $1.78 | $1.6M | Indirect | Sep 8, 2026 (5d) |
| Sep 2, 2026 | TENX | ↑ Buy | 770,333 | $1.79 | $1.4M | Indirect | Sep 2, 2026 (0d) |
| Aug 24, 2026 | TENX | ↑ Buy | 1,025,867 | $1.77 | $1.8M | Indirect | Aug 24, 2026 (0d) |
| Jul 31, 2026 | NXTC | ↑ Buy | 329,153 | $4.93 | $1.6M | Indirect | Aug 3, 2026 (3d) |
| Jul 29, 2026 | NXTC | ↑ Buy | 17,608 | $4.98 | $88K | Indirect | Jul 29, 2026 (0d) |
| Jul 15, 2026 | INM | ↑ Buy | 1,000 | $1.55 | $2K | Indirect | Jul 17, 2026 (2d) |
| May 19, 2026 | INM | ↑ Buy | 468,551 | $1.54 | $722K | Indirect | May 21, 2026 (2d) |
| May 19, 2026 | RLYB | ↑ Buy | 16,209 | $13.98 | $227K | Indirect | May 20, 2026 (1d) |
| May 15, 2026 | RLYB | ↑ Buy | 79,559 | $13.99 | $1.1M | Indirect | May 15, 2026 (0d) |
| May 12, 2026 | RLYB | ↑ Buy | 50,800 | $14.00 | $711K | Indirect | May 13, 2026 (1d) |
| May 5, 2026 | RLYB | ↑ Buy | 155,905 | $13.97 | $2.2M | Indirect | May 6, 2026 (1d) |
| Oct 15, 2025 | KROS | ↓ Sell | 4,391,237 | $17.75 | $77.9M | By ADAR1 Partners, LP | Oct 15, 2025 (0d) |
| Oct 15, 2025 | KROS | ↓ Sell | 743,358 | $17.75 | $13.2M | By Spearhead Insurance Solutions IDF, LL | Oct 15, 2025 (0d) |
| Oct 15, 2025 | KROS | ↓ Sell | 254,669 | $17.75 | $4.5M | By ADAR1 SPVI, LP | Oct 15, 2025 (0d) |
| Apr 9, 2025 | KROS | ↑ Buy | 917,893 | $10.14 | $9.3M | By ADAR1 Partners, LP | Apr 11, 2025 (2d) |
| Apr 9, 2025 | KROS | ↑ Buy | 16,365 | $9.40 | $154K | By Spearhead Insurance Solutions IDF, LL | Apr 11, 2025 (2d) |
| Aug 12, 2024 | PIRS | ↑ Buy | 5,243 | $15.32 | $80K | By: ADAR1 Partners | Aug 12, 2024 (0d) |
| Aug 12, 2024 | PIRS | ↑ Buy | 757 | $15.88 | $12K | By: Spearhead Insurance Solutions IDF, L | Aug 12, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NXTC insiders
Open-market trades in the last 12 months
About ADAR1 Capital Management, LLC's insider trades
ADAR1 Capital Management, LLC is a 10% owner of NextCure (NXTC). Since Aug 12, 2024, it has reported 23 open-market purchases worth $22.7M and 3 sales worth $95.7M on SEC Form 4. In the last 12 months: 19 buys ($13.2M).
Its filings also include other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NXTC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.